Further, TGF-β1 neutralizing antibody and erlotinib, an EGFR-specific inhibitor, both blocked EGF-induced COLI and COLIII in LF cells suggesting the involvement of EGF in the regulation of fibrotic signaling in LF [81]. This evidence concerns the gene TGFB1 and Lassa fever.